# AstraZeneca revenue entity: /record/astrazeneca.md predicate: revenue page: /record/astrazeneca/revenue as_of: 2026-11-09 cite: AsOf. "AstraZeneca revenue: 58,739,000,000 United States dollar", as of 2025-12-31. Claim clm_75285D1846DF, https://asof.is/claim/clm_75285D1846DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm. As of November 9, 2026, AstraZeneca's revenue on the AsOf record is $58.74 billion, dated December 31, 2025, from a primary source (sec.gov). 11 claims on AstraZeneca's revenue, 1 open and 10 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Current revenue What the record asserts on 2026-11-09. - [AstraZeneca](/record/astrazeneca.md) | revenue | 58,739,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_75285D1846DF](/claim/clm_75285D1846DF.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [AstraZeneca](/record/astrazeneca.md) | revenue | 24,708,000,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_904F793B66AA](/claim/clm_904F793B66AA.md) | [clm_E7354F8FC4AB](/claim/clm_E7354F8FC4AB.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 23,002,000,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_B25F0718A827](/claim/clm_B25F0718A827.md) | [clm_904F793B66AA](/claim/clm_904F793B66AA.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 22,465,000,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_790001197E10](/claim/clm_790001197E10.md) | [clm_B25F0718A827](/claim/clm_B25F0718A827.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465918015257/0001104659-18-015257-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 22,090,000,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_08D5EE5A62C8](/claim/clm_08D5EE5A62C8.md) | [clm_790001197E10](/claim/clm_790001197E10.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465919012881/0001104659-19-012881-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 24,384,000,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_85B6D134E13C](/claim/clm_85B6D134E13C.md) | [clm_08D5EE5A62C8](/claim/clm_08D5EE5A62C8.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465920028557/0001104659-20-028557-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 26,617,000,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_47272A7D1B25](/claim/clm_47272A7D1B25.md) | [clm_85B6D134E13C](/claim/clm_85B6D134E13C.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465921022456/0001104659-21-022456-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 37,417,000,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_31557855C15A](/claim/clm_31557855C15A.md) | [clm_47272A7D1B25](/claim/clm_47272A7D1B25.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465922025720/0001104659-22-025720-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 44,351,000,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_1A1A4ACC29CB](/claim/clm_1A1A4ACC29CB.md) | [clm_31557855C15A](/claim/clm_31557855C15A.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465923023818/0001104659-23-023818-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 45,811,000,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_5BDDB85A5719](/claim/clm_5BDDB85A5719.md) | [clm_1A1A4ACC29CB](/claim/clm_1A1A4ACC29CB.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465924025553/0001104659-24-025553-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 54,073,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_75285D1846DF](/claim/clm_75285D1846DF.md) | [clm_5BDDB85A5719](/claim/clm_5BDDB85A5719.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465925014750/0001104659-25-014750-index.htm - [AstraZeneca](/record/astrazeneca.md) | revenue | 58,739,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_75285D1846DF](/claim/clm_75285D1846DF.md) sources: https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/0001104659-26-019130-index.htm ## What replaced what - $24.71 billion (2015-12-31 to 2016-12-31, [clm_E7354F8FC4AB](/claim/clm_E7354F8FC4AB.md)) was replaced by $23 billion from 2016-12-31 ([clm_904F793B66AA](/claim/clm_904F793B66AA.md)) - $23 billion (2016-12-31 to 2017-12-31, [clm_904F793B66AA](/claim/clm_904F793B66AA.md)) was replaced by $22.47 billion from 2017-12-31 ([clm_B25F0718A827](/claim/clm_B25F0718A827.md)) - $22.47 billion (2017-12-31 to 2018-12-31, [clm_B25F0718A827](/claim/clm_B25F0718A827.md)) was replaced by $22.09 billion from 2018-12-31 ([clm_790001197E10](/claim/clm_790001197E10.md)) - $22.09 billion (2018-12-31 to 2019-12-31, [clm_790001197E10](/claim/clm_790001197E10.md)) was replaced by $24.38 billion from 2019-12-31 ([clm_08D5EE5A62C8](/claim/clm_08D5EE5A62C8.md)) - $24.38 billion (2019-12-31 to 2020-12-31, [clm_08D5EE5A62C8](/claim/clm_08D5EE5A62C8.md)) was replaced by $26.62 billion from 2020-12-31 ([clm_85B6D134E13C](/claim/clm_85B6D134E13C.md)) - $26.62 billion (2020-12-31 to 2021-12-31, [clm_85B6D134E13C](/claim/clm_85B6D134E13C.md)) was replaced by $37.42 billion from 2021-12-31 ([clm_47272A7D1B25](/claim/clm_47272A7D1B25.md)) - $37.42 billion (2021-12-31 to 2022-12-31, [clm_47272A7D1B25](/claim/clm_47272A7D1B25.md)) was replaced by $44.35 billion from 2022-12-31 ([clm_31557855C15A](/claim/clm_31557855C15A.md)) - $44.35 billion (2022-12-31 to 2023-12-31, [clm_31557855C15A](/claim/clm_31557855C15A.md)) was replaced by $45.81 billion from 2023-12-31 ([clm_1A1A4ACC29CB](/claim/clm_1A1A4ACC29CB.md)) - $45.81 billion (2023-12-31 to 2024-12-31, [clm_1A1A4ACC29CB](/claim/clm_1A1A4ACC29CB.md)) was replaced by $54.07 billion from 2024-12-31 ([clm_5BDDB85A5719](/claim/clm_5BDDB85A5719.md)) - $54.07 billion (2024-12-31 to 2025-12-31, [clm_5BDDB85A5719](/claim/clm_5BDDB85A5719.md)) was replaced by $58.74 billion from 2025-12-31 ([clm_75285D1846DF](/claim/clm_75285D1846DF.md)) ## Questions this record answers ### What is AstraZeneca's current revenue? $58.74 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts this claim as of November 9, 2026 (status valid, confidence 0.95). ### When did AstraZeneca's revenue last change? The latest value on the record is $58.74 billion, dated December 31, 2025; before it the record holds $54.07 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was AstraZeneca's revenue before $58.74 billion? $54.07 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/astrazeneca/revenue (markdown: /record/astrazeneca/revenue.md) - Entity twin: /record/astrazeneca.md ยท timeline: /timelines/astrazeneca.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.